Publication:
Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial

Placeholder

Organizational Units

Program

Authors

Authors

Panaccione, R.
Colombel, J-F.
Bossuyt, P.
Baert, F.
Vanasek, T.
Danalioglu, A.
Novacek, G.
Armuzzi, A.
Reinisch, W.
Johnson, S.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

Panaccione R., Colombel J., Bossuyt P., Baert F., Vanasek T., Danalioglu A., Novacek G., Armuzzi A., Reinisch W., Johnson S., et al., -Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial-, JOURNAL OF CROHNS & COLITIS, cilt.12, 2018

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads


Sustainable Development Goals